Cresco Labs
(CNSX) CL
Cresco Labs Financials at a Glance
Market Cap
$457.33M
Revenue (TTM)
$655.85M
Net Income (TTM)
$135.41M
EPS (TTM)
$-0.53
P/E Ratio
-2.42
Dividend
$0.00
Beta (Volatility)
1.13 (Average)
Dividend
$0.00
Beta (Volatility)
1.13 (Average)
Price
$1.28
Volume
195,081
Open
$1.38
Price
$1.28
Volume
195,081
Open
$1.38
Previous Close
$1.35
Daily Range
$1.23 - $1.39
52-Week Range
$0.60 - $3.12
Dividend
$0.00
Beta (Volatility)
1.13 (Average)
Price
$1.28
Volume
195,081
Open
$1.38
Previous Close
$1.35
Daily Range
$1.23 - $1.39
52-Week Range
$0.60 - $3.12
CL News
CL: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cresco Labs
Industry
Pharmaceuticals
Sector
Health CareEmployees
2,900
CEO
Charles Bachtell
Website
www.crescolabs.comHeadquarters
Chicago, IL 60654, US
CL Financials
Key Financial Metrics (TTM)
Gross Margin
49%
Operating Margin
10%
Net Income Margin
-21%
Return on Equity
-33%
Return on Capital
6%
Return on Assets
-12%
Earnings Yield
-41.32%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$457.33M
Shares Outstanding
357.29M
Volume
195.08K
Short Interest
0.00%
Avg. Volume
145.90K
Financials (TTM)
Gross Profit
$324.57M
Operating Income
$76.94M
EBITDA
$20.34M
Operating Cash Flow
$74.17M
Capital Expenditure
$35.75M
Free Cash Flow
$38.41M
Cash & ST Invst.
$90.92M
Total Debt
$583.10M
Cresco Labs Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$161.55M
-8.2%
Gross Profit
$72.72M
-13.5%
Gross Margin
45.01%
N/A
Market Cap
$457.33M
N/A
Market Cap/Employee
$157.70K
N/A
Employees
2,900
N/A
Net Income
$87.59M
-1903.4%
EBITDA
$38.88M
+19.9%
Quarterly Fundamentals
Net Cash
$492.18M
+2.0%
Accounts Receivable
$38.94M
-24.5%
Inventory
$0.00
-100.0%
Long Term Debt
$560.09M
-9.1%
Short Term Debt
$23.06M
-2.1%
Return on Assets
-11.56%
N/A
Return on Invested Capital
6.00%
N/A
Free Cash Flow
$18.72M
-28.0%
Operating Cash Flow
$27.88M
-5.4%